Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,522
archived clinical trials in
Chronic Pain

Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Atlanta, GA
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Chicago, IL
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Chicago, IL
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Wichita, KA
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Wichita, KA
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Bay City, MI
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Bay City, MI
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Caro, MI
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Caro, MI
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Grand Rapids, MI
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Somerset, NJ
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Somerset, NJ
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Greenville, NC
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Greenville, NC
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Charleston, SC
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Memphis, TN
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Bedford, TX
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Bedford, TX
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Cypress, TX
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Cypress, TX
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Houston, TX
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Houston, TX
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Riverton, UT
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Riverton, UT
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Norfolk, VA
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
mi
from
Elblag,
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
mi
from
Elblag,
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Costa Mesa, CA
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated:  9/25/2017
Clinical Research Facility
mi
from
Waxahachie, TX
Study of Efficacy, Safety of Fulranumab Monotherapy for OA of Hip or Knee, PAI3002
Randomized, 16-Week, Multi-Phase, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fulranumab as Monotherapy in Subjects With Signs and Symptoms of Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 9/25/2017
Clinical Research Facility
mi
from
Waxahachie, TX
Click here to add this to my saved trials
Virtual Reality in Inpatients
The Feasibility, Usability, Acceptability, and Clinical Utility of a Virtual Reality Intervention in the Inpatient Setting
Status: Enrolling
Updated:  9/27/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Virtual Reality in Inpatients
The Feasibility, Usability, Acceptability, and Clinical Utility of a Virtual Reality Intervention in the Inpatient Setting
Status: Enrolling
Updated: 9/27/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Combined Peripheral (BreEStim) and Central Electrical Stimulation (tDCS) for Neuropathic Pain Management - Healthy Subjects
Combined Peripheral (BreEStim) and Central Electrical Stimulation (tDCS) for Neuropathic Pain Management
Status: Enrolling
Updated:  10/1/2017
TIRR
mi
from
Houston, TX
Combined Peripheral (BreEStim) and Central Electrical Stimulation (tDCS) for Neuropathic Pain Management - Healthy Subjects
Combined Peripheral (BreEStim) and Central Electrical Stimulation (tDCS) for Neuropathic Pain Management
Status: Enrolling
Updated: 10/1/2017
TIRR
mi
from
Houston, TX
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Achieve Clinical Research
mi
from
Birmingham, AL
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Achieve Clinical Research
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Clinical Research Consulting, LLC
mi
from
Milford, CT
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Clinical Research Consulting, LLC
mi
from
Milford, CT
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Avail Clinical Research
mi
from
DeLand, FL
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Avail Clinical Research
mi
from
DeLand, FL
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Health Awareness
mi
from
Jupiter, FL
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Health Awareness
mi
from
Jupiter, FL
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Sunrise Medical Research
mi
from
Lauderdale Lakes, FL
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Sunrise Medical Research
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
International Clinical Research - US, LLC
mi
from
Sanford, FL
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
International Clinical Research - US, LLC
mi
from
Sanford, FL
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Miami Research Associates
mi
from
South Miami, FL
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Miami Research Associates
mi
from
South Miami, FL
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Best Clinical Trial, LLC
mi
from
New Orleans, LA
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Best Clinical Trial, LLC
mi
from
New Orleans, LA
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Healthcare Research Network
mi
from
Hazelwood, MO
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Healthcare Research Network
mi
from
Hazelwood, MO
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Omega Medical Research
mi
from
Warwick, RI
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Omega Medical Research
mi
from
Warwick, RI
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Clinical Trials of South Carolina
mi
from
Charleston, SC
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Clinical Trials of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Charlottesville Medical Research Center, LLC
mi
from
Charlottesville, VA
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Charlottesville Medical Research Center, LLC
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated:  10/2/2017
Coastal Carolina Research Center
mi
from
Mount Pleasant, SC
Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain
A Phase 2b Randomized, Double-Blind, Vehicle-Controlled, Repeat-Dose, Multi- Center, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Status: Enrolling
Updated: 10/2/2017
Coastal Carolina Research Center
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated:  10/4/2017
Delaware/Christiana Care NCORP
mi
from
Newark, DE
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated: 10/4/2017
Delaware/Christiana Care NCORP
mi
from
Newark, DE
Click here to add this to my saved trials
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated:  10/4/2017
Heartland NCORP
mi
from
Decatur, IL
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated: 10/4/2017
Heartland NCORP
mi
from
Decatur, IL
Click here to add this to my saved trials
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated:  10/4/2017
Metro Minnesota NCORP
mi
from
Minneapolis, MN
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated: 10/4/2017
Metro Minnesota NCORP
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated:  10/4/2017
University of Rochester
mi
from
Rochester, NY
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated: 10/4/2017
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated:  10/4/2017
Columbus NCORP
mi
from
Columbus, OH
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated: 10/4/2017
Columbus NCORP
mi
from
Columbus, OH
Click here to add this to my saved trials
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated:  10/4/2017
Dayton Oncology Research Program
mi
from
Dayton, OH
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer
Effectiveness of Prophylactic Topical Agents for Radiation Dermatitis
Status: Enrolling
Updated: 10/4/2017
Dayton Oncology Research Program
mi
from
Dayton, OH
Click here to add this to my saved trials
Dosing Study of Massage for Neck Pain
Dosing Study of Massage for Neck Pain
Status: Enrolling
Updated:  10/11/2017
Group Health Research Institute
mi
from
Seattle, WA
Dosing Study of Massage for Neck Pain
Dosing Study of Massage for Neck Pain
Status: Enrolling
Updated: 10/11/2017
Group Health Research Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase III Study Evaluating Topical Benzocaine for Treatment of Acute Otitis Media in Children
Phase III, Multicenter, Randomized, Double-Blind, Placebo- Controlled Parallel-Designed Evaluation to Assess Safety and Efficacy of Topical Benzocaine for Treatment of Pain Associated With Acute Otitis Media in Children Ages 5 to 12 Years
Status: Enrolling
Updated:  10/11/2017
Cyn3rgy Research
mi
from
Gresham, OR
Phase III Study Evaluating Topical Benzocaine for Treatment of Acute Otitis Media in Children
Phase III, Multicenter, Randomized, Double-Blind, Placebo- Controlled Parallel-Designed Evaluation to Assess Safety and Efficacy of Topical Benzocaine for Treatment of Pain Associated With Acute Otitis Media in Children Ages 5 to 12 Years
Status: Enrolling
Updated: 10/11/2017
Cyn3rgy Research
mi
from
Gresham, OR
Click here to add this to my saved trials
Burn Healing and Analgesia With Propranolol
The BURN HELP Trial: BURN Healing and AnaLgesia With Propranolol
Status: Enrolling
Updated:  10/16/2017
Washington Hospital Center
mi
from
Washington, D.C.,
Burn Healing and Analgesia With Propranolol
The BURN HELP Trial: BURN Healing and AnaLgesia With Propranolol
Status: Enrolling
Updated: 10/16/2017
Washington Hospital Center
mi
from
Washington, D.C.,
Click here to add this to my saved trials
Burn Healing and Analgesia With Propranolol
The BURN HELP Trial: BURN Healing and AnaLgesia With Propranolol
Status: Enrolling
Updated:  10/16/2017
North Carolina Jaycee Burn Center
mi
from
Chapel Hill, NC
Burn Healing and Analgesia With Propranolol
The BURN HELP Trial: BURN Healing and AnaLgesia With Propranolol
Status: Enrolling
Updated: 10/16/2017
North Carolina Jaycee Burn Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Burn Healing and Analgesia With Propranolol
The BURN HELP Trial: BURN Healing and AnaLgesia With Propranolol
Status: Enrolling
Updated:  10/16/2017
Wake Forest University Baptist
mi
from
Wake Forest, NC
Burn Healing and Analgesia With Propranolol
The BURN HELP Trial: BURN Healing and AnaLgesia With Propranolol
Status: Enrolling
Updated: 10/16/2017
Wake Forest University Baptist
mi
from
Wake Forest, NC
Click here to add this to my saved trials
Burn Healing and Analgesia With Propranolol
The BURN HELP Trial: BURN Healing and AnaLgesia With Propranolol
Status: Enrolling
Updated:  10/16/2017
Crozer-Chester Medical Center
mi
from
Upland, PA
Burn Healing and Analgesia With Propranolol
The BURN HELP Trial: BURN Healing and AnaLgesia With Propranolol
Status: Enrolling
Updated: 10/16/2017
Crozer-Chester Medical Center
mi
from
Upland, PA
Click here to add this to my saved trials
Ketamine: Comparison of IV Push vs. IV Drip
Comparison of Intravenous Push Dose of Low Dose Ketamine to Short Infusion of Low Dose Ketamine for Treatment of Moderate to Severe Pain in the Emergency Department: A Prospective, Randomized, Double-Blind Study
Status: Enrolling
Updated:  10/19/2017
Maimonides Medical Center
mi
from
Brooklyn, NY
Ketamine: Comparison of IV Push vs. IV Drip
Comparison of Intravenous Push Dose of Low Dose Ketamine to Short Infusion of Low Dose Ketamine for Treatment of Moderate to Severe Pain in the Emergency Department: A Prospective, Randomized, Double-Blind Study
Status: Enrolling
Updated: 10/19/2017
Maimonides Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Subcutaneous Botulinum Toxin for Cutaneous Allodynia
Subcutaneous Botulinum Toxin for Cutaneous Allodynia
Status: Enrolling
Updated:  10/23/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Subcutaneous Botulinum Toxin for Cutaneous Allodynia
Subcutaneous Botulinum Toxin for Cutaneous Allodynia
Status: Enrolling
Updated: 10/23/2017
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Enriched Autologous Fat Grafting for Treating Pain at Amputation Sites
Enriched Autologous Fat Grafting for Treating Pain at Amputation Sites
Status: Enrolling
Updated:  10/23/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Enriched Autologous Fat Grafting for Treating Pain at Amputation Sites
Enriched Autologous Fat Grafting for Treating Pain at Amputation Sites
Status: Enrolling
Updated: 10/23/2017
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials